Literature DB >> 18062796

Persistent of respiratory syncytial virus in human dendritic cells and influence of nitric oxide.

L Hobson1, M L Everard.   

Abstract

The annual epidemics of respiratory syncytial virus (RSV) infection are probably explained by poor herd immunity and the existence of a dormant reservoir of virus that is activated by an unknown trigger. The virus causes particular problems in infants, the elderly and patients with chronic obstructive airways disease (COPD). During two consecutive winters, human monocyte-derived dendritic cells (DCs) were exposed on a single occasion to one of two forms of RSV labelled with a fluorescent expresser genes (rgRSV or rrRSV) during the epidemic season. The cultures were maintained for many months, with fresh DCs being added at monthly intervals. The cultures were variously exposed to 600 parts per billion (ppb) nitric oxide for 15 min, nitric oxide (NO) donors and NO inhibitors outside the RSV epidemic season. The pattern of productive infection of DCs in vitro appeared to parallel the natural epidemics, in that DCs exhibited evidence of viral replication and productive infection only as manifested by intracellular fluorescence and infection of HeLa cells during the RSV epidemic season. When the long-term cultures were exposed to the above agents outside the RSV epidemic season there was again evidence of vigorous replication and productive infection, as shown by the reappearance of fluorescence and productive infection of HeLa cells. The results indicate that RSV may remain dormant in dendritic cells for prolonged periods and that replication appears to be activated by suppression of endogenous NO production. These observations may be key to our understanding of the mechanisms contributing to the annual epidemics of RSV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18062796      PMCID: PMC2276949          DOI: 10.1111/j.1365-2249.2007.03560.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  The effect of passive smoking on the development of respiratory syncytial virus bronchiolitis.

Authors:  F Gürkan; A Kiral; E Dağli; F Karakoç
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

2.  Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.

Authors:  T Seemungal; R Harper-Owen; A Bhowmik; I Moric; G Sanderson; S Message; P Maccallum; T W Meade; D J Jeffries; S L Johnston; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2001-11-01       Impact factor: 21.405

3.  Local variability in respiratory syncytial virus disease severity.

Authors:  A H Brandenburg; P Y Jeannet; H A Steensel-Moll; A Ott; P H Rothbarth; W Wunderli; S Suter; H J Neijens; A D Osterhaus; C A Siegrist
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

Review 4.  Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics.

Authors:  Martin L Moore; R Stokes Peebles
Journal:  Pharmacol Ther       Date:  2006-07-03       Impact factor: 12.310

5.  Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naïve T cells.

Authors:  H Bartz; O Türkel; S Hoffjan; T Rothoeft; A Gonschorek; U Schauer
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

6.  Replication of respiratory syncytial virus is inhibited in target cells generating nitric oxide in situ.

Authors:  Dania Ali-Ahmad; Cynthia A Bonville; Helene F Rosenberg; Joseph B Domachowske
Journal:  Front Biosci       Date:  2003-01-01

Review 7.  Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation.

Authors:  Peter F Bove; Albert van der Vliet
Journal:  Free Radic Biol Med       Date:  2006-05-26       Impact factor: 7.376

8.  Neutrophil survival is prolonged in the airways of healthy infants and infants with RSV bronchiolitis.

Authors:  A Jones; J M Qui; E Bataki; H Elphick; S Ritson; G S Evans; M L Everard
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

9.  Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection.

Authors:  M L Everard; A Swarbrick; M Wrightham; J McIntyre; C Dunkley; P D James; H F Sewell; A D Milner
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

10.  Serological indication for persistence of bovine respiratory syncytial virus in cattle and attempts to detect the virus.

Authors:  W H Van der Poel; J P Langedijk; J A Kramps; W G Middel; A Brand; J T Van Oirschot
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574

View more
  18 in total

1.  Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection.

Authors:  Daniel S McDermott; Kayla A Weiss; Cory J Knudson; Steven M Varga
Journal:  Future Virol       Date:  2011-08       Impact factor: 1.831

2.  Mapping the anatomy of respiratory syncytial virus infection of the upper airways in chinchillas (Chinchilla lanigera).

Authors:  Jessica L Grieves; Joseph A Jurcisek; Brian Quist; Russell K Durbin; Mark E Peeples; Joan E Durbin; Lauren O Bakaletz
Journal:  Comp Med       Date:  2010-06       Impact factor: 0.982

3.  A respiratory syncytial virus persistent-infected cell line system reveals the involvement of SOCS1 in the innate antiviral response.

Authors:  Junwen Zheng; Pu Yang; Yan Tang; Dongchi Zhao
Journal:  Virol Sin       Date:  2015-06-19       Impact factor: 4.327

4.  A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression.

Authors:  Olga Malykhina; Mark A Yednak; Peter L Collins; Paul D Olivo; Mark E Peeples
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

5.  Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2.

Authors:  Teresa R Johnson; Jason S McLellan; Barney S Graham
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

6.  Assessment of the relationship between exposure to air pollutants and COVID-19 pandemic in Tehran city, Iran.

Authors:  Davood Namdar-Khojasteh; Bijan Yeghaneh; Ali Maher; Farzaneh Namdar-Khojasteh; Jun Tu
Journal:  Atmos Pollut Res       Date:  2022-06-11       Impact factor: 4.831

7.  Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus.

Authors:  Teresa R Johnson; Christina N Johnson; Kizzmekia S Corbett; Gretchen C Edwards; Barney S Graham
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

Review 8.  Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities.

Authors:  Roberto P Garofalo; Deepthi Kolli; Antonella Casola
Journal:  Antioxid Redox Signal       Date:  2012-09-07       Impact factor: 8.401

Review 9.  Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility?

Authors:  Kristina M James; R Stokes Peebles; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2012-08       Impact factor: 10.793

Review 10.  Respiratory syncytial virus persistence in macrophages alters the profile of cellular gene expression.

Authors:  Evelyn Rivera-Toledo; Beatríz Gómez
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.